Cargando…

Phase II clinical trial of whole-brain irradiation plus three-dimensional conformal boost with concurrent topotecan for brain metastases from lung cancer

BACKGROUND: Patients with brain metastases from lung cancer have poor prognoses and short survival time, and they are often excluded from clinical trials. Whole-cranial irradiation is considered to be the standard treatment, but its efficacy is not satisfactory. The purpose of this phase II clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ge, Xiao-hui, Lin, Qiang, Ren, Xiao-cang, Liu, Yue-e, Chen, Xue-ji, Wang, Dong-ying, Wang, Yong-qiang, Cao, Bin, Li, Zhi-gang, Liu, Miao-ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853318/ https://www.ncbi.nlm.nih.gov/pubmed/24125485 http://dx.doi.org/10.1186/1748-717X-8-238

Ejemplares similares

Comparison of whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus versus whole brain radiotherapy for sequential brain metastases to boost irradiation in the treatment of brain metastases from SCLC: study protocol for a randomized controlled trial
por: Zhang, Xiaofang, et al.
Publicado: (2022)

Survival and quality of life after whole brain radiotherapy with 3D conformal boost in the treatment of brain metastases
por: Suteu, Patricia, et al.
Publicado: (2019)

The First Survival Score for Patients Treated with Whole-Brain Radiotherapy Plus Simultaneous Integrated Boost for Brain Metastases
por: Rades, Dirk, et al.
Publicado: (2023)

Whole brain radiation therapy plus focal boost may be a suitable strategy for brain metastases in SCLC patients: a multi-center study
por: Ni, Meng, et al.
Publicado: (2020)

A phase III trial of topotecan and whole brain radiation therapy for patients with CNS-metastases due to lung cancer
por: Neuhaus, T, et al.
Publicado: (2009)

Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2014)

Whole Brain Radiation Therapy Plus Focal Radiation Boost May Generate Better Survival Benefit for Brain Metastases From Non-small Cell Lung Cancer
por: Ni, Meng, et al.
Publicado: (2020)

Whole Brain Radiotherapy Plus Concurrent Chemotherapy in Non-Small Cell Lung Cancer Patients with Brain Metastases: A Meta-Analysis
por: Qin, Hong, et al.
Publicado: (2014)

PRO: Do We Still Need Whole-Brain Irradiation for Brain Metastases?
por: Popp, Ilinca, et al.
Publicado: (2023)

Propensity score-matched analysis comparing hippocampus-avoidance whole-brain radiotherapy plus simultaneous integrated boost with hippocampus‑avoidance whole-brain radiotherapy alone for multiple brain metastases-a retrospective study in multiple institutions
por: Wang, Xiaoliang, et al.
Publicado: (2023)

Application of piecewise VMAT technique to whole-brain radiotherapy with simultaneous integrated boost for multiple metastases
por: Xu, Yuan, et al.
Publicado: (2022)

Brain Radiotherapy plus Concurrent Temozolomide versus Radiotherapy Alone for Patients with Brain Metastases: A Meta-Analysis
por: Zhao, Qian, et al.
Publicado: (2016)

Radiosurgery alone versus radiosurgery plus whole-brain irradiation for very few cerebral metastases from lung cancer
por: Rades, Dirk, et al.
Publicado: (2014)

Whole-Brain Radiation Therapy With Simultaneous Integrated Boost Versus Whole-Brain Radiation Therapy Plus Stereotactic Radiosurgery for the Treatment of Brain Metastasis From Lung Cancer
por: Lin, Binwei, et al.
Publicado: (2021)

Risk factors to identify patients who may not benefit from whole brain irradiation for brain metastases - a single institution analysis
por: Buecker, Rebecca, et al.
Publicado: (2019)

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer
por: Tallet, Agnes V., et al.
Publicado: (2014)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Treatment plan comparison for irradiation of multiple brain metastases with hippocampal avoidance whole brain radiotherapy and simultaneous integrated boost using the Varian Halcyon and the Elekta Synergy platforms
por: Kraft, Johannes, et al.
Publicado: (2022)

Whole brain helical Tomotherapy with integrated boost for brain metastases in patients with malignant melanoma–a randomized trial
por: Hauswald, Henrik, et al.
Publicado: (2013)

Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma – final results of the BRAIN-RT trial
por: Hauswald, Henrik, et al.
Publicado: (2019)

Management of brain metastases with stereotactic radiosurgery alone versus whole brain irradiation alone versus both
por: El Gantery, Mahmoud M, et al.
Publicado: (2014)

Microbeam Irradiation as a Simultaneously Integrated Boost in a Conventional Whole-Brain Radiotherapy Protocol
por: Jaekel, Felix, et al.
Publicado: (2022)

Additional radiation boost to whole brain radiation therapy may improve the survival of patients with brain metastases in small cell lung cancer
por: Sun, Han, et al.
Publicado: (2018)

Concurrent whole brain radiotherapy and bortezomib for brain metastasis
por: Lao, Christopher D, et al.
Publicado: (2013)

Cardiac dose evaluation for 3Dimensional conformal partial breast irradiation compared with whole breast irradiation
por: Gale, Ashley A., et al.
Publicado: (2009)

Whole‐brain radiotherapy plus sequential or simultaneous integrated boost for the treatment of a limited number of brain metastases in non‐small cell lung cancer: A single‐institution study
por: Qing, Dong, et al.
Publicado: (2019)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Best Supportive Care Versus Whole-Brain Irradiation, Chemotherapy Alone, or WBRT Plus Chemotherapy in Patients With Brain Metastases From Small-Cell Lung Cancer: A Case-Controlled Analysis
por: Li, Hongwei, et al.
Publicado: (2021)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial
por: Lin, Qiang, et al.
Publicado: (2013)

Phase II randomized, double-blind, placebo-controlled study of whole-brain irradiation with concomitant chloroquine for brain metastases
por: Rojas-Puentes, Luis L, et al.
Publicado: (2013)

Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection—Outcome, Prognostic Factors, and Recurrence Patterns
por: El Shafie, Rami A., et al.
Publicado: (2020)

Intra‐CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases
por: Jaeckle, Kurt A., et al.
Publicado: (2020)

High-dose accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in locally advanced non-small-cell lung cancer: a feasibility study
por: Liu, Yue-E, et al.
Publicado: (2013)

Whole Brain Radiation Therapy Plus Stereotactic Radiosurgery in the Treatment of Brain Metastases Leading to Improved Survival in Patients With Favorable Prognostic Factors
por: Khan, Muhammad, et al.
Publicado: (2019)

Dosimetric evaluation of four whole brain radiation therapy approaches with hippocampus and inner ear avoidance and simultaneous integrated boost for limited brain metastases
por: Jiang, Aijun, et al.
Publicado: (2019)

Accelerated hypofractionated three-dimensional conformal radiation therapy (3 Gy/fraction) combined with concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer: preliminary results of an early terminated phase II trial
por: Ren, Xiao-Cang, et al.
Publicado: (2016)

Survival and intracranial control outcomes of whole-brain radiotherapy (WBRT) alone versus WBRT plus a radiotherapy boost in non-small-cell lung cancer with brain metastases: a single-institution retrospective analysis
por: Lu, Fei, et al.
Publicado: (2019)

A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases
por: Rades, Dirk, et al.
Publicado: (2017)

Prognostic factors for outcomes after whole-brain irradiation of brain metastases from relatively radioresistant tumors: a retrospective analysis
por: Meyners, Thekla, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_i8qtm5ukg0ge7sgiprm1jkh43o